Home Clinical Topics Who will benefit from mexiletine?

Who will benefit from mexiletine?

Author(s):

Researchers have identified a technique to determining which patients with a genetic mutation that cause long QT Syndrome type 3 will benefit from mexiletine.

Read more via theSource and Circulation Research.

LEAVE A REPLY

Please enter your comment!
Please enter your name here